AKT1 and prostate carcinoma: In vitro study in prostate cancer cell lines showed that the loss of tumour suppressor PTEN and subsequent activation of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway led to extensive cholesteryl ester accumulation.